Harvard Diabetes and Obesity Implications and Complications 2025

• Harvard Diabetes and Obesity: Implications and Complications 2025

  Introduction

  The Harvard Diabetes and Obesity: Implications and Complications 2025 course from Harvard Medical School delivers a comprehensive and clinically focused review of modern diabetes care, obesity medicine, and cardiometabolic disease management. Developed by leading Harvard faculty, this advanced continuing medical education program is designed to help clinicians navigate the rapidly evolving landscape of metabolic medicine, chronic disease prevention, and diabetes-related complications.

  As rates of obesity, type 2 diabetes, cardiovascular disease, chronic kidney disease, and metabolic dysfunction continue to rise globally, clinicians are increasingly challenged to manage complex patients with overlapping cardiometabolic disorders. Modern diabetes care now extends far beyond glycemic control, requiring integrated strategies involving weight management, cardiovascular protection, renal preservation, lifestyle intervention, and advanced pharmacotherapy.

  This course provides practical guidance on implementing contemporary treatment recommendations, emerging glucose-lowering therapies, obesity pharmacology, insulin technologies, continuous glucose monitoring systems, and multidisciplinary chronic disease management strategies. Through expert-led lectures and clinically relevant case discussions, participants gain actionable insight that can be directly applied in office-based practice, hospital medicine, endocrinology, and preventive cardiovascular care.

  Files Included

  The Harvard Diabetes and Obesity: Implications and Complications 2025 educational package includes comprehensive endocrinology and metabolic medicine learning materials for flexible self-paced study.

  Included resources:

  • Clinical diabetes management discussions
  • Obesity medicine educational modules
  • Continuous glucose monitoring reviews
  • Insulin therapy and diabetes technology sessions
  • Cardiometabolic disease management updates
  • Real-world patient case discussions
  • Lifestyle medicine and nutrition education

  These materials support advanced learning in diabetes management, obesity medicine, metabolic disease care, and cardiovascular risk reduction.

  Why This Course Is Important

  Diabetes and obesity remain among the leading causes of cardiovascular disease, chronic kidney disease, neuropathy, fatty liver disease, peripheral vascular disease, and long-term healthcare complications worldwide. Clinicians must now manage increasingly complex therapeutic pathways involving weight reduction, glucose optimization, renal protection, cardiovascular prevention, and individualized patient-centered care.

  At the same time, therapeutic innovation in metabolic medicine has accelerated dramatically with the expansion of GLP-1 receptor agonists, dual incretin therapies, SGLT2 inhibitors, modern insulin formulations, continuous glucose monitoring systems, and obesity pharmacotherapy. These developments are reshaping standards of care across endocrinology, primary care, nephrology, cardiology, and hospital medicine.

  Harvard Diabetes and Obesity: Implications and Complications 2025 addresses these clinical demands through a highly practical educational framework focused on obesity management, diabetes therapeutics, cardiometabolic disease prevention, chronic complication management, and personalized treatment strategies for patients with metabolic disorders.

  What Participants Will Learn

  Participants completing this course will strengthen their understanding of diabetes care, obesity medicine, and multidisciplinary cardiometabolic management.

  Learning objectives include:

  • Understanding the pathophysiology of type 1 and type 2 diabetes and their systemic complications
  • Applying office-based lifestyle interventions and obesity treatment strategies
  • Implementing updated pharmacologic therapies for diabetes and obesity management
  • Understanding cardiovascular and renal outcomes related to modern antidiabetes medications
  • Integrating insulin technologies and glucose monitoring systems into patient care
  • Managing diabetes-related complications involving cardiovascular, renal, neurologic, vascular, and hepatic systems
  • Improving care for elderly patients, pregnant patients, and hospitalized individuals with diabetes
  • Addressing healthcare disparities and communication barriers in diabetes management
  • Personalizing nutrition plans, exercise prescriptions, and weight reduction strategies
  • Enhancing patient engagement and multidisciplinary chronic disease care

  The curriculum integrates endocrinology, nephrology, obesity medicine, cardiology, lifestyle medicine, preventive care, and chronic disease management into a clinically practical educational experience.

  Full Course Topics & Lectures

  Diabetes Pathophysiology & Diagnosis

  Screening for Diabetes

  Diagnostic Criteria for Diabetes

  Diagnostic Criteria for Obesity

  Pathophysiology of Type 1 Diabetes

  Pathophysiology of Type 2 Diabetes

  Diabetes Progression and Comorbidity Development

  Obesity Medicine & Weight Management

  Clinical Approaches to Weight Management

  Lifestyle Interventions for Obesity

  Pharmacotherapy for Obesity

  Bariatric and Metabolic Surgery

  Individualized Lifestyle Modification Strategies

  Personalized Nutrition Plans

  Exercise Prescriptions in Metabolic Disease

  Pharmacologic Management of Diabetes

  Insulin Initiation and Intensification

  Selecting Insulin Therapies

  New Insulin Formulations

  Non-Insulin Therapies

  GLP-1 Receptor Agonists

  SGLT2 Inhibitors

  Combination Therapy Strategies

  Treating Type 2 Diabetes Not at Goal

  Diabetes Technology & Monitoring

  Glucose Monitoring Technologies

  Continuous Glucose Monitoring Systems

  Advances in Insulin Delivery

  Insulin Pumps and Technology Integration

  Cardiovascular & Renal Risk Reduction

  Cardiovascular Disease in Diabetes

  Cardiovascular Risk Reduction Strategies

  Dyslipidemia Management

  Hypertension in Diabetes

  Peripheral Vascular Disease

  Renal Outcomes Trials

  Chronic Kidney Disease in Diabetes

  Liver, Foot & Neurologic Complications

  Liver Disease in Diabetes and Obesity

  Neuropathy Management

  Diabetic Foot Disease

  Hypoglycemia Management

  Bone and Musculoskeletal Complications

  Special Populations & Individualized Care

  Diabetes in Older Adults

  Diabetes in Pregnancy

  Diabetes in Hospitalized Patients

  Obesity and Diabetes in High-Risk Populations

  Communication, Equity & Team-Based Care

  Motivational Communication Strategies

  Team-Based Diabetes Care

  Addressing Health Disparities

  Cultural, Social, and Racial Bias in Diabetes Care

  Patient Education and Resource Sharing

  Real-World Clinical Application

  Challenging Diabetes Patient Cases

  Office-Based Management Approaches

  Applying Emerging Therapeutic Advances

  Translating Guidelines into Practice

  Educational Experience & Learning Features

  The Harvard Diabetes and Obesity: Implications and Complications 2025 course combines advanced metabolic medicine education with practical chronic disease management strategies and real-world clinical application.

  Educational features include:

  • 69 expert-led video lectures
  • Clinical diabetes management discussions
  • Obesity medicine and weight management reviews
  • Continuous glucose monitoring and insulin technology updates
  • Lifestyle medicine and preventive care education
  • Real-world patient case discussions
  • Cardiometabolic disease management strategies
  • Guideline-focused therapeutic reviews
  • Multidisciplinary chronic disease education

  The curriculum integrates endocrinology, obesity medicine, cardiology, nephrology, diabetes technology, and preventive medicine into a clinically practical educational platform.

  Who Should Take This Course

  The Harvard Diabetes and Obesity: Implications and Complications 2025 course is intended for clinicians involved in diabetes care, obesity management, and chronic cardiometabolic disease treatment.

  This course is especially valuable for:

  • Endocrinologists
  • Internal medicine physicians
  • Family medicine physicians
  • Hospital medicine physicians
  • Cardiologists
  • Nephrologists
  • Geriatric medicine clinicians
  • Nurse practitioners
  • Physician assistants
  • Registered nurses
  • Pharmacists
  • Diabetes educators
  • Dietitians
  • Healthcare professionals managing metabolic disease and diabetes complications

  The curriculum is particularly relevant for clinicians seeking updated expertise in obesity pharmacotherapy, diabetes therapeutics, metabolic disease management, and cardiovascular risk reduction.

  Clinical Applications & Practice Benefits

  The course provides clinically relevant education focused on improving metabolic outcomes, obesity treatment strategies, and multidisciplinary chronic disease management.

  Participants gain practical insight into:

  • Glycemic management and insulin intensification strategies
  • Obesity treatment planning and weight reduction approaches
  • Cardiovascular and renal risk reduction in diabetes
  • Continuous glucose monitoring integration into clinical care
  • Management of diabetic neuropathy and diabetic foot disease
  • Chronic kidney disease and metabolic complication management
  • Nutritional counseling and exercise prescription planning
  • Addressing barriers to care and improving healthcare equity
  • Team-based patient communication and motivational interviewing strategies
  • Applying emerging pharmacologic therapies in everyday practice

  The educational content strengthens clinical confidence while supporting improved patient outcomes across diabetes and obesity care.

  Professional Summary

  The Harvard Diabetes and Obesity: Implications and Complications 2025 course from Harvard Medical School offers a comprehensive and clinically practical review of modern diabetes management, obesity medicine, and cardiometabolic disease prevention.

  From insulin therapies, GLP-1 receptor agonists, SGLT2 inhibitors, and glucose monitoring technologies to cardiovascular protection, chronic kidney disease management, obesity treatment strategies, neuropathy care, and lifestyle medicine, the curriculum explores the full spectrum of metabolic disease care through expert-led instruction and real-world clinical application.

  Its combination of therapeutic updates, practical office-based management strategies, multidisciplinary chronic disease education, and comprehensive metabolic medicine training makes this course a valuable educational resource for endocrinologists, internists, family physicians, hospital medicine clinicians, and healthcare professionals involved in diabetes and obesity management.

  .

Topics:

Schedule.pdf

Wednesday, Oct. 22, 2025
9:00am – 9:10am Introduction and Welcome: A Collective Call to Action
COMPREHENSIVE APPROACHES TO OBESITY: BLUNTING ITS IMPACT
9:10am – 9:43am Complementary & Alternative Medicines for Frank J. Domino, MD
Weight Loss, Diabetes and Life
9:43am – 10:13am Tailoring Nutrition for Success: Personalized Jody Dushay, MD, MMSc
Strategies for Weight Management*
10:13am – 10:28am Burning Clinical Question: I Want to Start a GLP-1 RA, Jody Dushay, MD, MMSc
but I’m Worried About Muscle Loss: What Is Known
and What Can I Do to Prevent It?
10:28am – 10:50am Q&A Session
10:50am – 11:00am BREAK AND STRETCH
11:00am – 11:28am Physiology of Exercise Maria Vamvini, MD
11:28am – 12:00pm Personalizing the Exercise Prescription: An Office- Edward M. Phillips, MD
Based Approach
12:00pm – 12:15pm Q&A Session
12:15pm – 1:00pm LUNCH BREAK
MEDICAL AND SURGICAL MANAGEMENT OF OBESITY
1:00pm – 1:42pm Pharmacologic Management of Obesity: Rapidly Osama Hamdy, MD, PhD, FACE
Expanding Options*
1:42pm – 2:16pm Modern Surgical Treatment of Obesity: Techniques Souheil W. Adra, MD, FACS, ABOM
and Patient Outcomes *
2:16pm – 2:30pm Q&A Session
2:30pm – 2:45pm BREAK AND REJUVENATION EXERCISES 
UPDATES ON THE MEDICAL MANAGEMENT OF DIABETES
2:45pm – 3:40pm Beyond Metformin: Navigating and Applying the Martin J. Abrahamson, MD, FACP,
New Guidelines and Reducing Cardiovascular Risk* FRCP (London)
3:40pm – 3:45pm BREAK AND STRETCH
3:45pm – 4:40pm Newer Insulins and How to Use Them: Richard S. Beaser, MD
A Comprehensive Primer
4:40pm – 4:55pm Burning Clinical Question: How Can I Learn to Count Gillian Arathuzik, RD, LDN, CDCES
Carbohydrates in 10 Minutes?
4:55pm – 5:10pm Burning Clinical Question: My Patient with Type 2 Martin J. Abrahamson, MD, FACP,
Diabetes Just Had a Stent – Do I Need to Change Their FRCP (London)
Medications?
Thursday, Oct. 23, 2025
9:00am – 9:20am Recap of Day 1 Richard S. Beaser, MD
MACROVASCULAR DISEASE AND DIABETES
9:20am – 10:05am Managing Hypertension in People with Diabetes: Melanie P. Hoenig, MD
Evolving Clinical Challenges
10:05am – 10:15am BREAK AND STRETCH
10:15am – 10:58am Managing Dyslipidemia in Diabetes: Om P. Ganda, MD, MBBS, MACE
Individualizing Treatment Options
10:58am – 11:10am Q&A Session
11:10am – 12:10pm KEYNOTE: Microbiome (The Second Human Genome): Sanjiv Chopra, MD, MACP, FRCP
What Shapes It and How It Shapes Us (London)
12:10pm – 1:00pm LUNCH BREAK
CARDIOVASCULAR DISEASE AND DIABETES
1:00pm – 1:32pm Management of Acute Coronary Syndromes and Donald E. Cutlip, MD
Chronic Cardiovascular Disease in Patients with
Diabetes
1:32pm – 2:14pm Diabetes and Heart Failure: Update on Management A. Reshad Garan, MD, MS, FACC
2:14pm – 2:30pm BREAK AND REJUVENATION EXERCISES 
2:30pm – 2:55pm Common Cardiovascular Tests and Their Optimal Michael C. Gavin, MD, MPH, FACC
Interpretation
2:55pm – 3:20pm Panel Discussion: Cardiovascular Care in People with A. Reshad Garan, MD, MS, FACC
Diabetes Michael C. Gavin, MD, MPH, FACC
Donald E. Cutlip, MD
3:20pm – 3:25pm BREAK AND STRETCH
MISCELLANEOUS
3:25pm – 4:15pm Metabolic-Associated Steatotic Liver Disease (MASLD) Sanjiv Chopra, MD, MACP, FRCP
(London)

4:15pm – 5:05pm Screening, Prevention, and Early Treatment of Jason L. Gaglia, MD, MMS
Type 1 Diabetes

Friday, Oct. 24, 2025
9:00am – 9:20am Recap of Day 2 Martin J. Abrahamson, MD, FACP,
FRCP (London)
Richard S. Beaser, MD
EMERGING TECHNOLOGIES AND CHALLENGES IN DIABETES
9:20am – 10:15am Tech-Enabled Diabetes Care: Tools and Innovations Anne Peters, MD
for Better Outcomes*
10:15am – 10:25am BREAK AND STRETCH
10:25am – 10:40am Burning Clinical Question: How Do I Start Insulin Richard S. Beaser, MD
in a Person Who Is Not Well Controlled on Non-
Insulin Medications?

10:40am – 11:30am Overcoming Hypoglycemia: Prevention and Mary-Elizabeth Patti, MD
Treatment in Modern Diabetes Care
11:30am – 11:35am BREAK AND STRETCH
11:35am – 12:25pm KEYNOTE The Expanding Universe of GLP-1 Daniel J. Drucker, FRS, FRCPC, OC
Medicines
12:25pm – 1:10pm LUNCH BREAK
1:10pm – 1:50pm Diabetes in Older Adults: Unique Perspectives in This Medha N. Munshi, MD
Important Population*
1:50pm – 2:35pm Inpatient Management of Diabetes: Strategies and Zachary H. Taxin, MD
Transition to the Outpatient Setting*

2:35pm – 2:50pm Q&A Session
2:50pm – 3:05pm BREAK AND REJUVENATION EXERCISES 
3:05pm – 3:50pm Future Therapies for Diabetes* Alan C. Moses, MD, FACP
3:50pm – 4:30pm Strategies to Promote Equity in Diabetes Care* Leonor Fernandez, MD
4:30pm – 4:40pm Q&A Session
4:40pm – 4:45pm BREAK AND STRETCH
4:45pm – 5:00pm Burning Clinical Question: How Do I Transition to Richard S. Beaser, MD
a Full Basal/Bolus Insulin Program?
5:00pm – 5:15pm Burning Clinical Question: How Do I Interpret My Martin J. Abrahamson, MD, FACP,
Patient’s CGM Data FRCP (London)
Saturday, Oct. 25, 2025
9:00am – 9:20am Recap of Day 3 Martin J. Abrahamson, MD, FACP,
FRCP (London)
Richard S. Beaser, MD
MULTIDISCIPLINARY CASE WORKSHOP: BRINGING KNOWLEDGE TOGETHER
9:20am – 10:25am Multidisciplinary Case Workshop and Panel Martin J. Abrahamson, MD, FACP,
Discussion FRCP (London)
Richard S. Beaser, MD
Melanie P. Hoenig, MD
Om P. Ganda, MD, MBBS, MACE
Donald E. Cutlip, MD
10:25am – 10:40am BREAK AND STRETCH
SPECIAL POPULATIONS AND MICROVASCULAR COMPLICATIONS
10:40am – 10:55am Burning Clinical Question: My Patient with Type 2 Florence M. Brown, MD
Diabetes Wants to Become Pregnant – How
Should I Counsel Her?*
10:55am – 11:10am Burning Clinical Question: My Patient with Type 1 Florence M. Brown, MD
Diabetes Just Found Out She Is Pregnant – What’s
the Optimal Management?*
11:10am – 12:00pm KEYNOTE: Artificial Intelligence in Medicine Adam M. Rodman, MD, MPH
12:00pm – 12:45pm LUNCH BREAK
12:45pm – 1:23pm Retinopathy in Diabetes: Innovations in Screening Deborah K. Schlossman, MD
and Treatment
1:23pm – 2:09pm Treatment of Renal Disease: Guidance to Blunt Melanie P. Hoenig, MD
the Impact and Slow the Progression
2:09pm – 2:20pm Q&A Session
2:20pm- 2:35pm BREAK AND REJUVENATION EXERCISES 
2:35pm – 3:20pm Evaluating and Treating Neuropathies of Diabetes: Patricia E. Greenstein, MBBCh
2025 Updates
3:20pm – 3:25pm BREAK AND STRETCH
THE DIABETIC FOOT
3:25pm – 4:02pm Preserving the Health of the Diabetic Foot: Practical John M. Giurini, DPM
Approaches *

4:02pm – 4:27pm Peripheral Vascular Disease in Diabetes: Innovations David R. Campbell, MD, FRCS,
and Best Practices FACS
4:27pm – 4:45pm Q&A Session
4:45pm – 4:50pm Indispensable Tips for Incorporating Updates into
Clinical Practice, and Closing Remarks

Official course reference: The Harvard course schedule runs October 22–25, 2025 and documents sessions on obesity therapy, GLP-1 medicines, insulin, cardiovascular and renal disease, diabetes technology, special populations and chronic complications. The official page describes live-streaming and provider materials; this MedicalAmboss purchase includes only the files supplied by the store and does not include Harvard platform access, live participation, CME credit or a certificate.